4.8 Article

Inhibition of β-catenin signaling by nongenomic action of orphan nuclear receptor Nur77

期刊

ONCOGENE
卷 31, 期 21, 页码 2653-2667

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2011.448

关键词

Nur77; beta-catenin; nongenomic; cardenolide; cancer

资金

  1. National Institutes of Health [CA140980, GM089927]
  2. US Army Medical Research and Material Command
  3. Xiamen University
  4. National Natural Science Foundation of China (NSFC) [30971445, NSCF-81001373]
  5. NSFC/Hong Kong Research Grants Council (RGC) [30931160431]
  6. Natural Science Foundation of Fujian Province [2009J01198]

向作者/读者索取更多资源

Dysregulation of beta-catenin turnover due to mutations of its regulatory proteins including adenomatous polyposis coli (APC) and p53 is implicated in the pathogenesis of cancer. Thus, intensive effort is being made to search for alternative approaches to reduce abnormally activated beta-catenin in cancer cells. Nur77, an orphan member of the nuclear receptor superfamily, has a role in the growth and apoptosis of cancer cells. Here, we reported that Nur77 could inhibit transcriptional activity of beta-catenin by inducing beta-catenin degradation via proteasomal degradation pathway that is glycogen synthase kinase 3 beta and Siah-1 independent. Nur77 induction of beta-catenin degradation required both the N-terminal region of Nur77, which was involved in Nur77 ubiquitination, and the C-terminal region, which was responsible for beta-catenin binding. Nur77/DDBD, a Nur77 mutant lacking its DNA-binding domain, resided in the cytoplasm, interacted with beta-catenin, and induced beta-catenin degradation, demonstrating that Nur77-mediated beta-catenin degradation was independent of its DNA binding and transactivation, and might occur in the cytoplasm. In addition, we reported our identification of two digitalis-like compounds (DLCs), H-9 and ATE-i2-b4, which potently induced Nur77 expression and beta-catenin degradation in SW620 colon cancer cells expressing mutant APC protein in vitro and in animals. DLC-induced Nur77 protein was mainly found in the cytoplasm, and inhibition of Nur77 nuclear export by the CRM1-dependent nuclear export inhibitor leptomycin B or Jun N-terminal kinase inhibitor prevented the effect of DLC on inducing beta-catenin degradation. Together, our results demonstrate that beta-catenin can be degraded by cytoplasmic Nur77 through their interaction and identify H-9 and ATE-i2-b4 as potent activators of the Nur77-mediated pathway for beta-catenin degradation. Oncogene (2012) 31, 2653-2667; doi:10.1038/onc.2011.448; published online 10 October 2011

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Ubiquitin-Specific Protease 4-Mediated Deubiquitination and Stabilization of PRL-3 Is Required for Potentiating Colorectal Oncogenesis

Cheng Xing, Xing-Xing Lu, Peng-Da Guo, Tong Shen, Shen Zhang, Xiao-Shun He, Wen-Juan Gan, Xiu-Ming Li, Jing-Ru Wang, Yuan-Yuan Zhao, Hua Wu, Jian-Ming Li

CANCER RESEARCH (2016)

Article Oncology

NUR77 exerts a protective effect against inflammatory bowel disease by negatively regulating the TRAF6/TLR-IL-1R signalling axis

Hua Wu, Xiu-Ming Li, Jing-Ru Wang, Wen-Juan Gan, Fu-Quan Jiang, Yao Liu, Xin-Dao Zhang, Xiao-Shun He, Yuan-Yuan Zhao, Xing-Xing Lu, Yan-Bing Guo, Xiao-Kun Zhang, Jian-Ming Li

JOURNAL OF PATHOLOGY (2016)

Article Gastroenterology & Hepatology

Elevated expression of Erbin destabilizes ERα protein and promotes tumorigenesis in hepatocellular carcinoma

Hua Wu, Su Yao, Shen Zhang, Jing-Ru Wang, Peng-Da Guo, Xiu-Ming Li, Wen-Juan Gan, Lin Mei, Tian-Ming Gao, Jian-Ming Li

JOURNAL OF HEPATOLOGY (2017)

Article Oncology

Orphan nuclear receptor Nur77 inhibits poly (I:C)-triggered acute liver inflammation by inducing the ubiquitin-editing enzyme A20

Xiu-Ming Li, Tian-Yu Yang, Xiao-Shun He, Jing-Ru Wang, Wen-Juan Gan, Shen Zhang, Jian-Ming Li, Hua Wu

ONCOTARGET (2017)

Article Multidisciplinary Sciences

Nur77 deficiency in mice accelerates tumor invasion and metastasis by facilitating TNFα secretion and lowering CSF-1R expression

Xiu-Ming Li, Jing-Ru Wang, Tong Shen, Shang-Shang Gao, Xiao-Shun He, Jiang-Nan Li, Tian-Yu Yang, Shen Zhang, Wen-Juan Gan, Jian-Ming Li, Hua Wu

PLOS ONE (2017)

Article Cell Biology

TRAF6 inhibits colorectal cancer metastasis through regulating selective autophagic CTNNB1/β-catenin degradation and is targeted for GSK3B/GSK3β-mediated phosphorylation and degradation

Hua Wu, Xing-Xing Lu, Jing-Ru Wang, Tian-Yu Yang, Xiu-Ming Li, Xiao-Shun He, Yi Li, Wen-Long Ye, Yong Wu, Wen-Juan Gan, Peng-Da Guo, Jian-Ming Li

AUTOPHAGY (2019)

Article Multidisciplinary Sciences

Oncogenic potential of truncated RXRα during colitis-associated colorectal tumorigenesis by promoting IL-6-STAT3 signaling

Xiaohong Ye, Hua Wu, Luoyan Sheng, Yi-xin Liu, Fang Ye, Mo Wang, Hu Zhou, Ying Su, Xiao-kun Zhang

NATURE COMMUNICATIONS (2019)

Article Oncology

KIAA1199 promotes sorafenib tolerance and the metastasis of hepatocellular carcinoma by activating the EGF/EGFR-dependent epithelial-mesenchymal transition program

Yanmin Xu, Huailong Xu, Mingyuan Li, Hua Wu, Yanhe Guo, Jun Chen, Juanjuan Shan, Xuejiao Chen, Junjie Shen, Qinghua Ma, Jingxia Liu, Meiling Wang, Wenxu Zhao, Juan Hong, Yanan Qi, Chao Yao, Qianzhen Zhang, Zhi Yang, Cheng Qian, Jianming Li

CANCER LETTERS (2019)

Article Gastroenterology & Hepatology

Tumor Necrosis Factor Receptor-Associated Factor 6 Promotes Hepatocarcinogenesis by Interacting With Histone Deacetylase 3 to Enhance c-Myc Gene Expression and Protein Stability

Hua Wu, Tian-Yu Yang, Yi Li, Wen-Long Ye, Feng Liu, Xiao-Shun He, Jing-Ru Wang, Wen-Juan Gan, Xiu-Ming Li, Shen Zhang, Yuan-Yuan Zhao, Jian-Ming Li

HEPATOLOGY (2020)

Article Immunology

TRIP6 promotes inflammatory damage via the activation of TRAF6 signaling in a murine model of DSS-induced colitis

Yun Yang, Xiu-Ming Li, Jing-Ru Wang, Yan Li, Wen-Long Ye, Yi Wang, Yu-Xuan Liu, Zhi-Yong Deng, Wen-Juan Gan, Hua Wu

Summary: TRIP6, a member of the zyxin family, serves as an adaptor protein to regulate various biological processes. Through interactions with TRAF6, it is shown to play a positive regulatory role in DSS-induced colitis, activating inflammatory TRAF6 signaling.

JOURNAL OF INFLAMMATION-LONDON (2022)

Article Biochemistry & Molecular Biology

Oncogenic potential of BEST4 in colorectal cancer via activation of PI3K/Akt signaling

Xiao-Shun He, Wen-Long Ye, Yu-Juan Zhang, Xiao-Qin Yang, Feng Liu, Jing-Ru Wang, Xiao-Lu Ding, Yun Yang, Ruo-Nan Zhang, Yuan-Yuan Zhao, Hai-Xia Bi, Ling-Chuan Guo, Wen-Juan Gan, Hua Wu

Summary: In this study, we found that BEST4 promotes cell proliferation and metastasis in colorectal cancer. It activates the Akt signaling pathway by binding to the regulatory subunit p85 alpha of PI3K, leading to the expression of critical regulators such as MYC and CCND1. Additionally, high expression of BEST4 is associated with poor prognosis in patients.

ONCOGENE (2022)

Article Biochemistry & Molecular Biology

Transcriptomic Analysis Identifies Complement Component 3 as a Potential Predictive Biomarker for Chemotherapy Resistance in Colorectal Cancer

Xiao-Shun He, Sheng-Yi Zou, Jia-Lu Yao, Wangjianfei Yu, Zhi-Yong Deng, Jing-Ru Wang, Wen-Juan Gan, Shan Wan, Xiao-Qin Yang, Hua Wu

Summary: The study identified complement component 3 (C3) gene as the hub gene associated with both FOLFOX resistance and CRC recurrence. High C3 expression was found to be detrimental for patient survival and oxaliplatin sensitivity in CRC. In addition, C3 expression correlated with tumor microenvironment changes and hyperactivation of pathways contributing to invasion, metastasis, lymph node spread, and oxaliplatin resistance in CRC samples.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Editorial Material Integrative & Complementary Medicine

Pharmacological Activities of Natural Products through the TGF-β Signalling Pathway

Chunpeng (Craig) Wan, Muhammad Farrukh Nisar, Hua Wu

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2022)

Article Biochemistry & Molecular Biology

TRIM21 is a druggable target for the treatment of metastatic colorectal cancer through ubiquitination and activation of MST2

Yu-Xuan Liu, Shan Wan, Xiao-Qin Yang, Yi Wang, Wen-Juan Gan, Wen-Long Ye, Xiao-Shun He, Jun-Jie Chen, Yun Yang, Xue-Mei Yang, Xin Guo, Xiao-Jiao Gao, Yi-Tan Lu, Zhi-Yong Deng, Guang Hu, Hua Wu

Summary: This study identified TRIM21 as a protein that inhibits invasion and metastasis in colorectal cancer through its interaction with MST2. It was also found that the antidepressant vilazodone can exert anti-metastatic effects by binding to TRIM21. These findings reveal a previously unrecognized interplay between TRIM21 and the Hippo-YAP signaling pathway, and suggest that vilazodone could be repurposed as an anti-tumor drug to inhibit colorectal cancer metastasis by targeting TRIM21.

CELL CHEMICAL BIOLOGY (2023)

Article Oncology

The long non-coding RNA NONHSAT062994 inhibits colorectal cancer by inactivating Akt signaling

Xiao-Shun He, Ling-Chuan Guo, Ming-Zhan Du, Shan Huang, Ren-Peng Huang, Sheng-Hua Zhan, Dong-Mei Gu, Wei-Shuo Liu, Xi-Ming Wang, Hua Wu, Wen-Juan Gan

ONCOTARGET (2017)

暂无数据